Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Total Non-Current Liabilities (2016 - 2026)

Apyx Medical filings provide 14 years of Total Non-Current Liabilities readings, the most recent being $51.7 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 2.81% to $51.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $51.7 million, a 2.81% increase, with the full-year FY2025 number at $51.7 million, up 2.81% from a year prior.
  • Total Non-Current Liabilities hit $51.7 million in Q4 2025 for Apyx Medical, up from $51.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $52.1 million in Q4 2023 to a low of $10.8 million in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $25.6 million (2023), compared with a mean of $31.4 million.
  • Biggest five-year swings in Total Non-Current Liabilities: fell 5.12% in 2022 and later skyrocketed 277.65% in 2023.
  • Apyx Medical's Total Non-Current Liabilities stood at $14.5 million in 2021, then fell by 5.12% to $13.8 million in 2022, then skyrocketed by 277.65% to $52.1 million in 2023, then decreased by 3.59% to $50.2 million in 2024, then grew by 2.81% to $51.7 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $51.7 million (Q4 2025), $51.0 million (Q3 2025), and $50.4 million (Q2 2025) per Business Quant data.